[Boot:J618]

Safe Save Medical Cell Sciences & Technology, SSC, is the pioneer of immunotherapy in Taiwan, founded in 2011 by Wen Kung, Yang MD, PhD. who is the leading brain cancer export in Taiwan. With proven clinical trial outcomes of safe, effcicay, having almost no side effects's product, as well as ahead running the one and only phase III immunotherpy clinical trail, strive to bring the bright hope to the cancer paitients, SSC is in the leading role of immunotherpay in Taiwan.

SSC's Autologous Dendritic Cell/Tumor Antigen, ADCTA and Dendritic Cell – Ccytokine Iinduced Kkiller Ccell, ADCTAK cancer treatments are developed to meet the urgent unmet need for cancer patitents.

Clinical Trial:
1. GBM PIII is the leading clinical trial in Taiwan, 9 centers will not stop recruit till 2024 or further.
[start in 2019~: LK-CGMH, KL-CGMH, CY-CGMH, KS-CGMG, TCGVH, CMH, NCHUH]
[start in 2023: TC-CGMH, EDA]
2. NSCLC PII expected to kick off in the early of 2023, 3 centers will not stop to recruit till 2024 or further.

Clinical Treatment:
There are 4 centers and 3 to come in 2023 offer paid ADCTA treatment while forementioned clinical trial screening exclusion may happen.
[start in 2019: LK-CGMH, CSH, CMH, LY-CMH]
[start in 2024: TCGVH, EDA, TC-CGMH, EverAn]

SSC welcome and value every potential coorperation, contact us at any time, thanks.